RELOMBI Trademark

Trademark Overview

On Monday, May 23, 2005, a trademark application was filed for RELOMBI with the United States Patent and Trademark Office. The USPTO has given the RELOMBI trademark a serial number of 78635106. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 20, 2009. This trademark is owned by AstraZeneca AB. The RELOMBI trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS OF THE RESPIRATORY SYSTEM, CENTRAL NERVOUS SYSTEM, PERIPHERAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM, OR GASTRO-INTESTINAL SYSTEM; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR USE IN PAIN CONTROL, ANAESTHESIA, ONCOLOGY, INFECTION, INFLAMMATION
relombi

General Information

Serial Number78635106
Word MarkRELOMBI
Filing DateMonday, May 23, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 20, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2006

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS OF THE RESPIRATORY SYSTEM, CENTRAL NERVOUS SYSTEM, PERIPHERAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM, OR GASTRO-INTESTINAL SYSTEM; PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR USE IN PAIN CONTROL, ANAESTHESIA, ONCOLOGY, INFECTION, INFLAMMATION

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 31, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE-151 85
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151 85
SE

Trademark Events

Event DateEvent Description
Monday, July 20, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 20, 2009ABANDONMENT - NO USE STATEMENT FILED
Friday, December 12, 2008EXTENSION 5 GRANTED
Wednesday, December 3, 2008EXTENSION 5 FILED
Friday, December 12, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 3, 2008TEAS EXTENSION RECEIVED
Thursday, June 12, 2008EXTENSION 4 GRANTED
Thursday, June 12, 2008EXTENSION 4 FILED
Thursday, June 12, 2008TEAS EXTENSION RECEIVED
Thursday, January 10, 2008EXTENSION 3 GRANTED
Thursday, December 13, 2007EXTENSION 3 FILED
Thursday, December 13, 2007TEAS EXTENSION RECEIVED
Thursday, September 6, 2007EXTENSION 2 GRANTED
Tuesday, June 12, 2007EXTENSION 2 FILED
Tuesday, June 12, 2007TEAS EXTENSION RECEIVED
Monday, June 11, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 11, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 12, 2007EXTENSION 1 GRANTED
Tuesday, December 19, 2006EXTENSION 1 FILED
Tuesday, December 19, 2006TEAS EXTENSION RECEIVED
Tuesday, June 20, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2006PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2006NOTICE OF PUBLICATION
Wednesday, February 8, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 6, 2006ASSIGNED TO LIE
Friday, February 3, 2006ASSIGNED TO LIE
Wednesday, February 1, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2006AMENDMENT FROM APPLICANT ENTERED
Tuesday, January 10, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 10, 2006PAPER RECEIVED
Thursday, December 15, 2005NON-FINAL ACTION E-MAILED
Thursday, December 15, 2005NON-FINAL ACTION WRITTEN
Thursday, December 15, 2005ASSIGNED TO EXAMINER
Tuesday, May 31, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

relombi system pharmaceutical nervous preparations substances control pain intestinal anaesthesia inflammation